Memory performance in healthy elderly without Alzheimer's disease: Effects of time and apolipoprotein-E

Neurobiology of Aging

Volumn 22, Issue 4, 2001, Pages 683-689

  Mayeux, Richard ^a,b   Small, Scott A ^a,b   Tang, Ming Xin ^a,b   Tycko, Benjamin ^b   Stern, Yaakov ^a,b  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; PROTEIN SUBUNIT;

AGE; AGING; ALLELE; ALZHEIMER DISEASE; AMNESIA; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; EDUCATION; FACTORIAL ANALYSIS; FEMALE; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SENESCENCE; TIME;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS;

EID: 0034974216     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00223-8     Document Type: Article

References (69)

1. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease
2. Apo E influences declarative and procedural learning in age-associated memory impairment
3. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease
4. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults
5. Evaluating storage, retention, and retrieval in disordered memory and learning
6. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease
7. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/-mice: Isoform-specific effects on neurodegeneration
8. Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice
9. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function
10. Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes
11. Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice
12. Relation of education to brain size in normal aging: Implications for the reserve hypothesis
13. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly
14. Behavioral deficits in APP(V717F) transgenic mice deficient for the apolipoprotein E gene
15. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
16. In an epidemiological sample the apolipoprotein E4 allele is associated to dementia and loss of memory function only in the very old
17. Biochemical and cognitive studies of apolipoprotein-E-deficient mice
18. Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E epsilon4 status
19. The association of apolipoprotein E polymorphism with memory: A population based study
20. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans
21. beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury
22. The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: Evidence of common mechanisms and utility of animal models
23. A new clinical scale for the staging of dementia
24. Apolipoprotein E and cognitive change in an elderly population
25. Neuropsychological detection and characterization of preclinical Alzheimer's disease
26. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia
27. Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures
28. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele
29. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease
30. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes
31. Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risks
32. Mental status examination for organic mental syndrome in the elderly patient
33. APOE allele frequencies in demented and nondemented elderly Jamaicans
34. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults
35. Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants
36. Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis
37. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females
38. Apolipoprotein E and cognitive performance
39. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease
40. Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent
41. Low education is a genuine risk factor for accelerated memory decline and dementia
42. The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis
43. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
44. Apolipoprotein E e4 allele in the normal elderly: Neuropsychologic and brain MRI correlates
45. Apolipoprotein E genotype and progression of Alzheimer's disease: The Rotterdam Study
46. Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia
47. Is APOE - Epsilon4 a risk factor for cognitive impairment in normal aging?
48. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
49. Selective decline in memory function among healthy elderly
50. Apolipoprotein E genotypes and cognitive functions in healthy elderly persons
51. Rate of memory decline in AD is related to education and occupation: Cognitive reserve?
52. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education
53. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease
54. Normative data for a brief neuropsychological battery administered to English- and Spanish-speaking community-dwelling elders
55. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City
56. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics
57. Incidence rates for Alzheimer's disease among black, Caribbean Hispanic and white elderly living in northern Manhattan
58. Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture
59. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients
60. Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease
61. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women
62. Models for longitudinal data: A generalized estimating equation approach